An evidence-based FITIGER regulatory and preparedness guide explaining the 2025 AHA adult choking sequence, FDA's 2026 Class II QXN category, product-specific authorization, facility verification, and the proper second-line role of suction anti-choking devices.

The Thomas Telford choking case shows why dysphagia liability depends on tray verification, supervision, first-line rescue, and second-line escalation after manual response fails.

National choking incident data shows where airway emergencies concentrate and why future response plans need first-line rescue, role clarity, retrieval-time measurement, and second-line QXN readiness after failed BLS.

Explore why 2025 AHA guidelines and 2026 FDA protocols keep manual choking rescue first. Learn how QXN suction boundaries define second-line backup safety.

This article explains how restaurants, hotels, offices, factories, banquet venues, and dense workplaces can audit choking readiness through reach-time, staff roles, OSHA visibility, second-line planning, and incident documentation.

This article explains how choking rescue cases can be used as readiness tests for schools, childcare centers, restaurants, assisted-living facilities, nursing homes, and families without overstating what any single rescue story proves.

This article explains how schools, care facilities, restaurants, hotels, and procurement teams can evaluate 2026 airway safety compliance through reach-time, role clarity, QXN verification, dysphagia controls, and second-line backup access.

An engineering-led explanation of how connected rescue systems can shorten the communication and retrieval gap during airway emergencies in schools, child care settings, and care facilities.

A 2026 engineering-led analysis of how airway safety is moving from an emergency accessory to a documented risk-management asset in nursing homes, assisted living, and care facilities. Covers CMS SFF pressure, SNF QRP payment exposure, insurance disclosure, physical redundancy, and operational audits.

A B2B Fitiger guide to 2026 lifecycle compliance for second-line airway technologies, built around market entry, traceability, post-market surveillance, vigilance, and controlled change management across the U.S., EU, Canada, and Australia.

A long-term care operations article on turning choking and near-choking incidents into QAPI performance-improvement work. Covers event data fields, latency mapping, post-event monitoring, second-line-device documentation, and 2026 CMS oversight pressure.

A technical and regulatory Fitiger article explaining the difference between FDA registration, listing, and authorization for anti-choking devices in 2026. Covers QXN, 21 CFR 874.5400, the 2025 import alert, and why authorization is a performance-control signal as well as a legal status.

State-level airway-safety legislation is no longer a side conversation. New Jersey, Georgia, New York, and Maryland are forcing schools and child care operators to think harder about location, training, policy language, and second-line readiness. This article explains what each bill is doing, why the FDA's second-line framework changes implementation, how procurement teams should think about certified versus counterfeit suction performance, and where special-education and retrieval-path planning

A 2026 pillar guide for schools, child care centers, and care facilities on how airway safety is changing under state legislative activity, FDA second-line treatment rules, training expectations, human factors, and institution-level readiness planning.

A system-first Fitiger article for families, schools, and eldercare teams explaining why airway safety starts with prevention, fast recognition, first-line action, and visible backup readiness rather than last-second product mythology.

A Fitiger engineering guide to 2026 IEP choking safety compliance, covering Texas SB 57, Section 504, silent aspiration risk, and FDA second-line boundaries for school planning.

This article explains why severe choking in aged care is often a latency problem before it becomes a rescue problem. It connects swallowing risk, frailty, PBJ staffing exposure, F689 supervision expectations, and the limited second-line role of suction backup after unsuccessful first-line response.

A practical FITIGER explainer on what the 2026 FDA authorization changed and what it didn't. Covers second-line treatment, AHA first-line response, redundancy planning, procurement risk, and the difference between authorized products and lookalike devices.